| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |